Safety and Efficacy of IBE-814 Intravitreal (IVT) Implant - a Sustained, Low Dose Dexamethasone Therapy
Clinical trial NCT04576689 · COMPLETED
Trial details
- NCT number
- NCT04576689
- Sponsor
- Ripple Therapeutics Pty Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-30
- Primary completion
- 2023-04-25
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.